siRNA treatment reduces triglycerides in patients with rare condition

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran reduced triglyceride levels by 80% as well as reduced the threat of pancreatitis in people along with persistent chylomicronemia, with or even without a genetic prognosis.

Articles You Can Be Interested In

• US Politics
• Philanthropy
• Career Advice
• Tax Planning
• Philanthropy
• Credit
• US Politics
• World Sports
• Space Exploration
• Data Science
• Logistics
• Startup News
• Savings
• Entertainment
• Management
• AI & ML
• Augmented Reality
• Real Estate
• Public Speaking
• Tax Planning